A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

February 29, 2008

Conditions
Coronary Artery Disease
Interventions
DEVICE

TAXUS Express Paclitaxel-Eluting Coronary Stent System

Paclitaxel-Eluting Coronary Stent System

DEVICE

Control stent

control stent

Trial Locations (1)

53721

HELIOS Clinic, Siegburg

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT00297804 - A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions | Biotech Hunter | Biotech Hunter